155 results on '"Sripichai, Orapan"'
Search Results
2. Down-regulation of the transcriptional repressor ZNF802 (JAZF1) reactivates fetal hemoglobin in β0-thalassemia/HbE
3. UNC0638 induces high levels of fetal hemoglobin expression in β-thalassemia/HbE erythroid progenitor cells
4. Visual genotyping of thalassemia by using pyrrolidinyl peptide nucleic acid probes immobilized on carboxymethylcellulose-modified paper and enzyme-induced pigmentation
5. Genetic variation of Krüppel-like factor 1 (KLF1) and fetal hemoglobin (HbF) levels in β0-thalassemia/HbE disease
6. Induction of fetal hemoglobin: Lentiviral shRNA knockdown of HBS1L in β0-thalassemia/HbE erythroid cells
7. Association between SCN5A and sudden unexplained nocturnal death syndrome in Thai decedents: a case–control study
8. In Vitro Study of Ineffective Erythropoiesis in Thalassemia: Diverse Intrinsic Pathophysiological Features of Erythroid Cells Derived from Various Thalassemia Syndromes
9. Induction of fetal hemoglobin: Lentiviral shRNA knockdown of HBS1L in β0-thalassemia/HbE erythroid cells.
10. Impaired Terminal Erythroid Maturation in β0-Thalassemia/HbE Patients with Different Clinical Severity
11. Clinical Severity of β-Thalassemia Pediatric Patients in Myanmar
12. Lysine-Specific Histone Demethylase 1 Inhibition Enhances Robust Fetal Hemoglobin Induction in Human β0-Thalassemia/Hemoglobin E Rrythroid Cells
13. MTAP-related increased erythroblast proliferation as a mechanism of polycythaemia vera
14. Association of the Degree of Erythroid Expansion and Maturation Arrest with the Clinical Severity of β0-Thalassemia/Hemoglobin E Patients
15. Cytokine-mediated increases in fetal hemoglobin are associated with globin gene histone modification and transcription factor reprogramming
16. Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells
17. A genome-wide association identified the common genetic variants influence disease severity in β0-thalassemia/hemoglobin E
18. Association of SNP in exon 1 of HBS1L with hemoglobin F level in β0-thalassemia/hemoglobin E
19. Coinheritance of the different copy numbers of α-globin gene modifies severity of β-thalassemia/Hb E disease
20. Prevalence and antimicrobial susceptibility of Campylobacter isolated from retail chickens in Thailand
21. Genomic Study in β-Thalassemia
22. Down-regulation of the transcriptional repressor ZNF802 (JAZF1) reactivates fetal hemoglobin in β0-thalassemia/HbE.
23. Impaired Terminal Erythroid Maturation in β 0 -Thalassemia/HbE Patients with Different Clinical Severity.
24. Development of DNA controls for detection of β‐thalassemia mutations commonly found in Asian
25. High‐level induction of fetal haemoglobin by pomalidomide in β‐thalassaemia/HbE erythroid progenitor cells
26. Characterization and identification of Hb Bart’s hydrops fetalis caused by a compound heterozygous mutation ‐‐ SEA /‐‐ CR , a novel α 0 ‐thalassemia deletion
27. Downregulation of Transcription Factor LRF/ZBTB7A Increases Fetal Hemoglobin Expression in β-Thalassemia/Hemoglobin E Erythroid Cells
28. ZNF802 (JAZF1), a Possible New Therapeutic Target for Treatment of β-Thalassemia
29. Association of the Degree of Erythroid Expansion and Maturation Arrest with the Clinical Severity of β0-Thalassemia/Hemoglobin E Patients.
30. Recent advances in the laboratory diagnosis of thalassaemia: 50
31. A scoring system for the classification of β-thalassemia/Hb E disease severity
32. Genetic Analysis of Candidate Modifier Polymorphisms in Hb E-β0-Thalassemia Patients
33. Genetic modifiers of Hb E/β0 thalassemia identified by a two-stage genome-wide association study
34. Characterization and identification of Hb Bart's hydrops fetalis caused by a compound heterozygous mutation ‐‐SEA/‐‐CR, a novel α0‐thalassemia deletion.
35. Comparison of gene expression profiles between human erythroid cells derived from fetal liver and adult peripheral blood
36. Intrinsic Pathophysiological Features of Erythroid Cells Derived From Various Thalassemia Syndromes
37. Histone Modification Levels are Correlated with the Severity of -Thalassemia/Hbe Patients
38. Genetic variation of Krüppel-like factor 1 (KLF1) and fetal hemoglobin (HbF) levels in β0-thalassemia/HbE disease
39. AB045. Molecular markers for disease severity in beta thalassemia/Hb E disease
40. Fetal hemoglobin regulation in β-thalassemia: heterogeneity, modifiers and therapeutic approaches
41. 3071 - Histone Modification Levels are Correlated with the Severity of -Thalassemia/Hbe Patients
42. 3072 - Intrinsic Pathophysiological Features of Erythroid Cells Derived From Various Thalassemia Syndromes
43. Genetic variation of Krüppel-like factor 1 (KLF1) and fetal hemoglobin (HbF) levels in β0-thalassemia/HbE disease.
44. Insight into the Peopling of Mainland Southeast Asia from Thai Population Genetic Structure
45. HbF-Inducing Cytokines and BCL11A shRNA Have Combined Effects Upon Globin Gene Reprogramming In Adult Human Erythroblasts
46. Genetic modifiers of Hb E/β0 thalassemia identified by a two-stage genome-wide association study
47. Ineffective Erythropoiesis Caused by Phenylhydrazine Activates the Expression of GDF15 in Maturing Erythroblasts.
48. During Terminal Differentiation, HbF-Inducing Cytokines Cause Decreased Expression and Reduced Globin Locus Occupancy of BCL11A in Human Erythroblasts.
49. A genome-wide association identified the common genetic variants influence disease severity in β0-thalassemia/hemoglobin E
50. Gamma-Globin Gene Expression in Adult Human Erythroblasts Is Associated with Concurrent Changes in the Nuclear Protein Levels of at Least Seven Transcription Factors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.